GlassScriptPhysician profile
Sahar Chitgar
NPI 1780993311
$1,494.57
in general payments reported to CMS, 2019-2025
19 companies · $499 in 2025
The $499 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.64 · 2022: $123 · 2023: $445 · 2024: $377 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Education: $96.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.02 |
| Education | $96.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $371.77 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $313.73 | 2024-2025 | Slynd |
| Amgen INC. | $167.82 | 2022-2024 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $93.96 | 2024-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $67.59 | 2024 | |
| Hologic Sales and Service, LLC | $67.23 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $55.70 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $53.80 | 2022-2024 | Farxiga |
| Exact Sciences Corporation | $46.04 | 2023 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $41.19 | 2022 | |
| Shield Therapeutics INC | $36.00 | 2023-2024 | Accrufer |
| Janssen Pharmaceuticals, INC | $30.12 | 2024 | Xarelto |
| Pfizer INC. | $29.36 | 2025 | |
| Biogen, INC. | $28.83 | 2025 | Zurzuvae |
| Inspire Medical Systems, INC. | $24.84 | 2023 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $20.04 | 2024 | Saxenda, Wegovy |
| Paratek Pharmaceuticals, INC. | $17.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.63 | 2023 | |
| Coopersurgical, INC. | $13.20 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sahar Chitgar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.